Abstract
The prevalence of obesity has become an epidemic.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Flegal, K., Carroll, M., Ogden, C., and Johnson, C. Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002; 288: 1723–7.
Bray, G. Medical consequences of obesity. J. Clin. Endocrinol. Metab. 2004; 89: 2583–9.
Lukanova, A., Bjor, O., Kaaks, R., et al. Body mass index and cancer: Results from the Northern Sweden Health and Disease Cohort. Int. J. Cancer 2006; 118: 458–66.
Bianchini, F., Kaaks, R., and Vainio, H. Overweight, obesity, and cancer risk. Lancet Oncol. 2002; 3: 565–74.
Clemons, M., and Goss, P. Estrogen and the risk of breast cancer. N. Engl. J. Med. 2001; 344: 276–85.
Key, T. Serum oestradiol and breast cancer risk. Endocrinol. Relat. Cancer 1999; 6: 175–80.
Reaven, G. Are insulin resistance and/or compensatory hyperinsulinemia involved in the etiology and clinical course of patients with hypertension? Int. J. Obes. 1995; 19(Suppl 1): S2–5.
Kaaks, R., Lukanova, A., and Kurzer, M. Obesity, endogenous hormones, and endometrial cancer risk: A synthetic review. Cancer Epidemiol. Biomarkers Prev. 2002; 11: 1531–43.
Khandwala, H., McCutcheon, I., Flyvbjerg, A., and Friend, K. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr. Reb. 2000; 21: 215–44.
Hammarsten, J., and Hogstedt, B. Hyperinsulineaemia: A prospective risk factor for lethal clinical prostate cancer. Eur. J. Cancer 2005; 41: 2887–95.
Persson, I. Estrogens in the causation of breast, endometrial and ovarian cancers: Evidence and hypotheses from epidemiological findings. J. Steroid Biochem. Mol. Biol. 2000; 74: 357–64.
Giovannucci, E. Insulin, insulin-like growth factors and colon cancer: A review of the evidence. J. Nutr. 2001; 131: 3109S–3120S.
Morita, T., Tabata, S., Mineshita, M., Mizoue, T., Moore, M., and Kono, S. The metabolic syndrome is associated with increased risk of colorectal adenoma development: The Self-Defense Forces Health Study. Asian Pac. J. Cancer Prev. 2005; 6: 485–9.
Furberg, A.-S., Veierod, M. Wilsgaard, T., Bernstein, L., and Thune, I. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J. Natl. Cancer Inst. 2004; 96: 1152–60.
Furberg, A.-S., Jasienska, G., Bjurstam, N., et al. Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study. Cancer Epidemiol. Biomarkers Prev. 2005; 14: 33–40.
Ray, G., and Husain, S. Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin. Biochem. 2001; 34: 71–6.
Caro, J., Sinha, M., Kolaczynski, J., Zhang, P., and Considine, R. Leptin: The tale of an obesity gene. Diabetes 1996; 45: 1455–62.
Considine, R., Sinha, M., Heiman, M., et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Eng. J. Med. 1996; 334: 292–5.
Sierra-Honigmann, M., Nath, A., Murakami, C., et al. Biological action of leptin as an angiogenic factor. Science 1998; 281: 1683–6.
Bouloumie, A., Drexler, H., Lafontan, M., and Busse, R. Leptin, the product of Ob gene, promotes angiogenesis. Circ. Res. 1998; 83: 1059–66.
Ribeiro, R., Lopes, C., and Medeiros, R. The link between obesity and prostate cancer: The leptin pathway and therapeutic perspectives. Prostate Cancer Prostatic Dis. 2006; 9: 19–24.
Stattin, P., Soderberg, S., Hallmans, G., et al. Leptin associated with increased prostate cancer risk: A nested case-referent study. J. Clin. Endocrinol. Metab. 2001; 86: 1341–5.
Cleary, M., Phillips, F., Getzin, S., et al. Genetically obese MMTV-TGF-alpha/Lep(ob)Lep(ob) female mice do not develop mammary tumors. Breast Cancer Res. Treat. 2003; 77: 205–15.
Ishikawa, M., Kitayama, J., and Nagawa, H. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin. Cancer Res. 2004; 10: 4325–31.
Hardwick, J., Van Den Brink, G., Offerhaus, G., Van Deventer, S., Peppelenbosch, M. Leptin is a growth factor for colonic epithelial cells. Gastroenterology 2001; 121: 79–90.
Garofalo, C., and Surmacz, E. Leptin and cancer. J. Cell Physiol. 2006; 207: 12–22.
Goodwin, P., and Boyd, N. Body size and breast cancer prognosis: A critical review of the evidence. Breast Cancer Res. Treat. 1990; 16: 205–14.
Rock, C., and Demark-Wahnefried, W. Nutrition and survival after the diagnosis of breast cancer: A reveiw of the evidence. J. Clin. Oncol. 2002; 20: 3302–16.
Bastarrachea, J., Hortobagyi, G., Smith, T., Kau, S.-W, and Buzdar, A. Obesity is an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer. Ann. Intern. Med. 1993; 119: 18–25.
Chlebowski, R., Aiello, E., and McTieman, A. Weight loss in breast cancer patient management. J. Clin. Oncol. 2002; 20: 1128–43.
Ballard-Barbash, R. Anthropometry and breast cancer. Cancer 1994; 74: 1090–1100.
Amling, C. The association between obesity and the progression of prostate and renal cell carcinoma. Urol. Oncol. 2004; 22: 478–84.
Kroenke, C., Chen, W., Rosner, B., and Holmes, M. Weight, weight gain, and survival after breast cancer diagnosis. J. Clin. Oncol. 2005; 23: 1345–7.
Calle, E., Rodriquez, C., Walker-Thurmond, K., and Thun, M. Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. N. Engl. J. Med. 2003; 348: 1625–38.
Demark-Wahnefried, W., Rimer, B., and Winer, E. Weight gain in women diagnosed with breast cancer. J. Am. Diet. Assoc. 1997; 97: 519–29.
Chlebowski, R., Weiner, J., Reynolds, R., Luce, J., Bulcavage, L., and Bateman, J. Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy. Breast Cancer Res. Treat. 1986; 7: 23–9.
Caan, B., Sternfeld, B., Gunderson, E., Coates, A., Quesenberry, C.J., and Slattery, M. Life After Cancer Epidemiology (LACE) Study: A cohort of early stage breast cancer survivors (United States). Cancer Causes Control 2005; 16: 545–56.
Irwin, M., Crumley, D., McTiernan, A., et al. Physical activity levels before and after a diagnosis of breast carcinoma: The Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer 2003; 97: 1746–57.
Rock, C., Mc Eligot, A., Flatts, S., et al. S. Eating pathology and obesity in women at risk for breast cancer recurrence. Int. J. Eat. Disord. 2000; 27: 172–9.
Demark-Wahnefried, W., Peterson, B., Winer, E., et al. Changes in weight, body composition, and factors in influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J. Clin. Oncol. 2001; 19: 2381–9.
Aslani, A., Smith, R., Allen, B., Pavlakis, N., Levi, J. Changes in body composition during breast cancer chemotherapy with the CMF-regimen. Breast Cancer Res. Treat. 1999; 57: 285–90.
Pierce, J., Newman, V., Flatt, S., et al. Telephone counseling intervention increases intakes of micronutrient- and phytochemical-rich vegetables, fruit and fiber in breast cancer survivors. J. Nutr. 2004; 134: 452–8.
Thomson, C., Rocs Giuliano, A., Newton, T., Gui, H., Reid, P., Green, T., and Alberts, D. Women's Healthy Eating & Living Study Group. Longitudinal changes in body weight and body composition among women previously treated for breast cancer consuming a high-vegetable, fruit and fiber, low fat diet. Eur. J. Nutr. 2005; 44: 18–25.
Rock, C., Flatt, S., Thomson, C., et al. Effects of a high-fiber, low-fat diet intervention on serum concentrations of reproductive steroid hormones in women with a history of breast cancer. J. Clin. Oncol. 2004; 22: 2379–87.
Coups, E., and Ostroff, J. A population-bsed estimate of the prevalence of behavioral risk factors maong adult cancer surviviors and noncancer controls. Prev. Med. 2005; 40: 702–11.
Blanchard, C., Denniston, M., Baker, F., et al. Do adults change their lifestyle behaviors after a cancer diagnosis? Am. J. Health Behav. 2003; 27: 246–56.
Jen, K.-L.C., Djuric, Z., DiLaura, N., et al. Improvement of metabolism among obese breast cancer survivors in differing weight loss regimens. Obes. Res. 2004; 12: 306–12.
Djuric, Z., DiLaura, N., Jenkins, I., et al. Combining weight-loss counseling with Weight Watchers Plan for obese breast cancer survivors. Obes. Res. 2002; 10: 657–65.
Demark-Wahnefried, W., Aziz, N., Rowland, J., and Pinto, B. Riding the crest of the teachable moment: Promoting long-term health after the diagnosis of cancer. J. Clin. Oncol. 2005; 23: 5814–30.
Bray, G. Health hazards of obesity. Endocrinol. Metab. Clin. N. Am. 1996; 25: 907–19.
Goodrick, G., and Foreyt, J. Why treatment for obesity don't last? J. Am. Diet. Assoc. 1991; 91: 1243–7.
Lu, H., Buison, A., Uhley, V., Jen, K.-L.C. Long-term weight cycling in female Wistar rats: Effects on metabolism. Obes. Res. 1995; 3: 521–30.
Uhley, V., Pellizzon, M., Buison, A., Guo, F., Djuric, Z., Jen, K.-L. Chronic weight cycling increases oxidative DNA damage levels in mammary gland of female rats fed a high-fat diet. Nutr. Cancer 1997; 29: 55–9.
Djuric, Z., Heilbrun, L., Simon, M., et al. Levels of 5-hydroxymethly-2'-deoxyuridine in DAN from blood as a marker of breast cancer. Cancer 1996; 77: 691–6.
Buison, A., Pellizzon, M., Brogan, K., Baranes, M., Jen, K.-L.C. Weight cycling did not increase tumor incidence in high fat-fed rats treated with a low-dose 7,12-dimethylbenzyl(1)anthracene. Nutr. Res. 2005; 25: 1097–108.
Cleary, M., Jacobson, M., Phillips, F., Getzin, S., Grande, J., and Maihle, N. Weight-cycling decreases incidence and increases latency of mammary tumores to a greater extent than does chronic caloric restriction in mouse mammary tumor virus-transforming growth factor-a female mice. Cancer Epidemiol. Biomarkers Prev. 2002; 11: 836–43.
Atkins, R. Dr. Artkins' New Diet Revolution. Simon & Schuster: New York, 1998.
Steward, H., Bethea, M., Andrew, S., and Balart, L. Sugar Busters Ballantine Books: New York, 1995.
Eades, M., and Eades, M. Protein Power. Bantam Books, NY, 1996.
Heller, R., and Heller, R. The Carbohydrate Addict's Diet. Penguin Books: New York, 1991.
Foster, G., Wyatt, H., Hill, J., et al. A randomized trial of a low-carbohydrate diet for obesity. N. Engl. J. Med. 2003; 348: 2082–90.
Stern, L., Iqbal, N., Seshadri, P., et al. The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: One-year follow-up of a randomized trial. Ann. Intern. Med. 2004; 140: 778–85.
Meckling, K., O'Sullivan, C., and Saari, D. Comparison of a low-fat diet to a low-carbohydrate diet on wieght loss, body composition, and risk factors for diabetes and cardiovascular disease in free-living, overweight men and women. J. Clin. Endocrinol. Metab. 2004; 89: 2717–23.
Astrup, A., Larsen, T., and Harper, A. Atkins and other low-carbohydrate diets: Hoax or an effective tool for weight loss? Lancet 2004; 364: 897–9.
St. Jeor, S., Howard, B., Prewitt, E., et al. Dietary protein and weight reduction. A statement for Healthcare Professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation 2001; 104: 1869–74.
Nickols-Richardson, S., Coleman, M., Volpe, J., and Hosig, K. Perceived hunger is lower and weight loss is greater in overweight premenopausal women consuming a low-carbohydrate/high-protein vs high-carbohydrate/low-fat diet. J. Am. Diet Assoc. 2005; 105: 1433–7.
Blundell, J., and Macdiarmid, J. Fat as a risk factor for overconsumption: Satiation, satiety, and patterns of eating. J. Am. Diet Assoc. 1997; 97(Suppl): S63–S69.
Yancy, W., Jr., Olsen, M., Guyton, J., Bakst, R., and Westman, E. A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: A randomized, controlled trial. Ann. Intern. Med. 2004; 140: 769–77.
Dansinger, M., Gleason, J., Griffith, J., Selker, H., and Schaefer, E. Comparison of the Atkins, Omish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction. JAMA 2005; 293: 43–53.
Denke, M. Metabolic effects of high-protein, low-carbohydrate diets. Am. J. Cardiol. 2001; 88: 59–61.
LaRosa, J., Gordon, A., Muesing, R., and Rosing, D. Effects of high-protein, low-carbohydrate dieting on plasma lipoproteins and body weight. J. Am. Diet Assoc. 1980; 77: 264–70.
Baron, J., Schori, A., Crow, B., Carter, R., and Mann, J. A randomized controlled trial of low carbohydrate and low fat/high fiber diets for weight loss. Am. J. Public Health 1986; 76: 1293–6.
Worthington, B., and Taylor, L. Balanced low-calorie vs high-protein-low carbohydrate reducing diets. II. Biochemical changes. J. Am. Diet. Assoc. 1974; 64: 52–5.
National Institutes of Health Consensus Development Panel. National Institute of Health Consensus Development Conference statement: Adjuvant therapy for breast cancer., November 1–2, 2000. J.Natl. Cancer Inst. Monogr. 2001; (30): 5–15.
Kayl, A., and Meyers, C. Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients. Curr. Opin. Obstet. Gynecol. 2006; 18: 24–8.
Barzel, U., and Massey, L. Excess dietary protein can adversely affect bone. J. Nutr. 1998; 128: 1051–3.
Theriault, R. Pathophysiology and implications of cancer treatment-induced bone loss. Oncology 2004; 18(Suppl 3): 11–15.
Jen, K.-L.C., Buison, A., Darga, L., and Nelson, D. The relationship between blood leptin levela nd bone density is specific to ethnicity and menopausal status. J. Lab. Clin. Med. 2005; 146: 18–24.
Yang, C., Kuroishi, T., Huang, X., Inoue, M., and Tajima, K. Correlation between food consumption and colorectal cancer: An ecological analysis in Japan. Asian Pac. J. Cancer Prev. 2002; 3: 77–83.
Handa, K., and Kreiger, N. Diet patterns and the risk of renal cell carcinoma. Public Health Nutr. 2002; 5: 757–67.
Nagle, C., Purdie, D., Webb, P., Green, A., Harvey, P., and Bain, C. Dietary influences on survival after ovarian cancer. Int. J. Cancer 2003; 106: 264–9.
Hewitt, M., Rowland, J., and Yancik, R. Cancer survivors in the United States: Age, health, and disability. J. Gerontol. A Biol. Sci. Med. Sci. 2003; 58: 82–91.
Pritikin, R. The New Pritikin Program. Simon & Schuster Inc.: New York, 1990.
Pritikin, R. The Pritikin Principle. Time Life Books: Alexandria, VA, 2000.
Ornish, D. Dr. Ornish's Program for Reversing Heart Disease. Ballentine Books: New York, 1990.
Ornish, D. Eat More, Weight Less. Harper Paperbacks: New York, 1993.
Barnard, R. Effects of life-style modification on serum lipids. Arch. Intern. Med. 1991; 151: 1389–94.
Barnard, R., Ugianskis, E., Martin, D. Inkel, S. Role of diet and exercise in the management of hyperinsulinemia and associated atherosclerotic risk factors. Am. J. Cardiol. 1992; 69: 440–4.
Ornish, D., Scherwitz, L.B., J.H., Brown S, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998; 280: 2001–7.
Havel, P., Kasim-Karakas, S., Mueller, W., Johnson, P., Gingerich, R., and Stern, J. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: Effects of dietary fat content and sustained weight loss. J. Clin. Endocrinol. Metab. 1996; 81: 4406–13.
Astrup, A., Grunwald, G., Melanson, E., Saris, W., and Hill, J. The role of low-fat diets in body weight control: A meta-analysis of ad libitum dietary intervention studies. Int. J. Obes. 2000; 24: 1545–52.
Lara-Castro, C., and Garvey, W. Diet, insulin resistance, and obesity: Zoning in on data for Atkins dieters living in South Beach. J. Clin. Endocrinol. Metab. 2004; 89: 4197–205.
Nordmann, A., Nordmann, A., Briel, M., et al. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: A meta-analysis of randomized controlled trials. Arch. Intern. Med. 2006; 166: 285–93.
Schaefer, E., Gleason, J., and Dansinger, M. The effects of low-fat, high-carbohydrate diets on plasma lipoprotein, weight loss, and heart disease risk reduction. Curr. Atheroscler. Rep. 2005; 7: 421–7.
Kant, A., and Graubard, B. Energy density of diets reproted by American adults: Association with food group intake, nutrient intake, and body weight. Int. J. Obes. Relat. Metab. Disord. 2005; 29: 950–6.
Drewnowski, A., Almiron-Roig, E., Marmonier, C., and Lluch, A. Dietary energy density and body weight: Is there a relationship? Nutr. Rev. 2004; 62: 403–13.
Powell, J., Tucker, L., Fisher, A., and Wilcox, K. The effects of different percentages of dietary fat intake, exercise, and calorie restriction on body composition and body weight in obese females. Am. J. Health Promot. 1994; 8: 442–8.
Djuric, Z., Uhley, V.D., Depp. J.B., Brooks, K., Lababidi, S., and Heilbrun, L. A clinical trial to selectively change dietary fat and/or energy intake in women: The Women's Diet Study. Nutr. Cancer 1999; 34: 27–35.
Kasim-Karakas, S., Almario, R., Mueller, W., and Peerson, J. Changes in plasma lipoproteins during low-fat, high-carbohydrate diets: Effects of energy intake. Am. J. Clin. Nutr. 2000; 71: 1439–47.
Raben, A., Jensen, N.D., Marckmann, P., Sandstrom, B., and Astrup, A. Spontaneous weight loss during 11 weeks' ad libitum intake of a low fat/high fiber diet in young, normal weight subjects. Int. J. Obes. 1995; 19: 916–23.
Prewitt, T., Schmeisser, D., Bowen, P., et al. Changes in body weight, body composition, and energy intake in women fed high- and low-fat diets. Am. J. Clin. Nutr. 1991; 54: 304–10.
Hays, N., Starling, R. Li, X., Sullivan, D., Trappe, T., Fluckey, J., and Evans, W. Effects of an ad libitum low-fat, high-carbohydrate diet on body weight, body composition, and fat distribution in older men and women: A randomized controlled trial. Arch. Intern. Med. 2004; 164: 210–17.
Zhang, S., Folsom, A., Sellers, T., Kushi, L., and Potter, J. Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. Cancer 1995; 76: 275–83.
Chlebowski, R., Blackburn, G., Buzzard, I., et al. Adherence to dietary fat intake reduction program in postmenopausal women receiving therapy for early stage breast cancer. The Women's Intervention nutrition Study. J. Clin. Oncol. 1993; 11: 2072–80.
Pierce, J., Faerber, S., Wright, F., et al. A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: The Women's Healthy Eating and Living (WHEL) Study. Control Clin. Trials 2002; 23: 728–56.
Chlebowski, R., and Grosvenor, M. The scope of nutrition intervention trials with cancer-related endpoints. Cancer 1994; 74: 2734–8.
Kristal, A., Shattuck, A., Bowen, D., Sponzo, R., and Nixon, D. Feasibility of using volunteer research staff to deliver and evaluate a low-fat dietary intervention: The American Cancer Society Breast Cancer Dietary Intervention Project. Cancer Epidemiol. Biomarkers Prev. 1997; 6: 459–67.
Sargrad, K., Homko, C., Mozzoli, M., and Boden, G. Effect of high protein vs high carbohydrate intake on insulin sensitivity, body weight, hemoglobin A1C, and blood pressure in patients with type 2 diabetes mellitus. J. Am. Diet. Assoc. 2005; 105: 573–80.
Noakes, M., Leogh, J., Foster, P., and Clifton, P. Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women. Am. J. Clin. Nutr. 2005; 81: 1298–1306.
Gerhard, G., Ahmann, A., Meeuws, K., McMurry, M., Duell, P., and Connor, W. Effects of a low-fat diet compared with those of a high-monounsaturated fat diet on body weight, plasma lipids and lipoproteins, and glycemic control in type 2 diabetes. Am. J. Clin. Nutr. 2004; 80: 668–73.
Schaefer, E., Lichtenstein, A., Lamon-Fava, S., i Body weight and low-density lipoprotein cholesterol changes after consumption of a low-fat ad libitum diet. JAMA 1995; 274: 1450–5.
Wolever, T., and Mehling, C. High-carbohydrate-low-glycaemic index dietary advice improves glucose disposition index in subjects with imparied glucose tolearnce. Br. J. Nutr. 2002; 87: 477–87.
Anderson, J., Chen, W., and Sieling, B. Hypolipidemic effect of high-carbohydrate, high-fiber diet. Metabolism 1980; 29: 827–31.
Byers, T., Nestle, M., McTieman, A., et al. American cancer Society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J. Clin. 2002; 52: 92–119.
Blundell, J., Green, S., and Burley, V. Carbohydrates and human appetite. Am. J. Clin. Nutr. 1994; 59(Suppl 3): 728S–734S.
McGuire, M., Wing, R., Klem, M., and Hill, J. Behavioral strategies of individual who have maintained long-term weight losses. Obes. Res. 1999; 7: 334–41.
Leser, M., Yanovski, S.Y., and Janovski, A. A low-fat intake and greater activity level are associated with lower weight regain 3 years after completing a very-low-calorie diet. J. Am. Diet. Assoc. 2002; 102: 1252–6.
Wing, R., and Phelan, S. Long-term weight loss maintenance. Am. J. Clin. Nutr. 2005; 82(1 Suppl): 222S–225S.
Weigle, D., Cummings, D.N., Newby, P.D., Breen, P., Frayo, R., Matthys, C.C., H.S., and Purnell, J. Roles of leptin and ghrelin in the loss of body weight casued by a low fat, high carbohydrate diet. J. Clin. Endocrinol. Metab. 2003; 88: 1577–86.
Appel, L., Moore, T., Obazanek, E., et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N. Engl. J. Med. 1997; 336: 1117–24.
Ernst, N., Cleeman, J., Mullis, R., Sooter-Bochenek, J., Van Horn, L. The National Cholesterol Education Program: Implications for dietetic practitioners from the Adult Treatment Panel recommendations. J. Am. Diet. Assoc. 1988; 88: 1401–8.
Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. National Academy Press: Washington, DC, 2002.
Noakes, M., and Clifton, P. Changes in plasma lipids and other cardiovascular risk factors during 3 energy-restricted diets differing in total fat and fatty acid composition. Am. J. Clin. Nutr. 2000; 71: 706–12.
Alford, B.B., Blankenship, A.C., and Hagne, R. The effects of variations in carbohydrate, protein, and fat content of the diet upon weight loss, blood values, and nutrient intake of adult obese women. J. Am. Diet. Assoc. 1990; 90: 534–40.
National Institutes of Health NH, Lung, and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The evidence report. 1998.
Marshall, J., Bessesen, D., and Hamman, R. High saturated fat and low starch and fiber are associated with hyperinsulinemia in a non-diabetic population: The San Luis Valley Diabetes Study. Diabetologia 1997; 40: 430–8.
World Health Organization. Diet, Nutrition and the Prevention of Chronic Diseases: Report of a Joint WHO/FAO Expert Consultation. WHO: Geneva, Switzerland, 2003. WHO technical report series 916.
Borkman, M., Storlein, L., Pan, D., Jenkins, A., Chisholm, D., and Campbell, L. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N. Engl. J. Med. 1993; 328: 238–44.
Larsson, S.K., Kumlin, M., Ingelman-Sundberg, M., and Wolk, A. Dietary long-chain n-3 fatty acids for the prevention of cancer: A review of potential mechanisms. Am. J. Clin. Nutr. 2004; 79: 935–45.
MacLean, C., Newberry, S., Mojicaa, W., et al. Effects of omega-3 fatty acids on cancer risk. JAMA 2006; 295: 403–15.
Simopoulos, A. Ω -3 fatty acids in the prevention-management of cardiovascular disease. Can. J. Physiol. Pharmacol. 1997; 75: 234–9.
Brown, J., Byers, T., Doyle, C., et al. Nutrition and physical activity during and after cancer treatment: An American Cancer Society guide for informed choices. CA Cancer J. Clin. 2003; 53: 268–91.
American Cancer Society. Cancer Facts and Figures 2002. American Cancer Society: Atlanta, GA, 2002.
U.S. Department of Agriculture and U.S. Department of Health and Human Services. Nutrition and Your Health: Dietary Guidelines for Americans. Home and Garden Bulletin no 232. 2000.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer
About this chapter
Cite this chapter
Uhley, V., Jen, KL.C. (2007). Nutrition and Weight Management in Cancer Survivors. In: Feuerstein, M. (eds) Handbook of Cancer Survivorship. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-34562-8_15
Download citation
DOI: https://doi.org/10.1007/978-0-387-34562-8_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-34561-1
Online ISBN: 978-0-387-34562-8
eBook Packages: MedicineMedicine (R0)